Changes in Diagnosis of Thyroid Cancer Among Medicaid Beneficiaries Following Medicaid Expansion

Ari D Schuman; Matthew E Spector; Craig A Jaffe; Andrew G Shuman; Steven B Chinn; Scott E Regenbogen; Andrew J Rosko

doi:10.1001/jamasurg.2020.3290

Changes in Diagnosis of Thyroid Cancer Among Medicaid Beneficiaries Following Medicaid Expansion

JAMA Surg. 2020 Nov 1;155(11):1080-1081. doi: 10.1001/jamasurg.2020.3290.

Authors

Ari D Schuman^{1

2}, Matthew E Spector³, Craig A Jaffe⁴, Andrew G Shuman³, Steven B Chinn³, Scott E Regenbogen^{5

6}, Andrew J Rosko³

Affiliations

¹ University of Michigan Medical School, Ann Arbor.
² Now with Bobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
³ Department of Otolaryngology-Head and Neck Surgery, University of Michigan, Ann Arbor.
⁴ Endocrine Section, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.
⁵ Department of Surgery, University of Michigan, Ann Arbor.
⁶ Center for Healthcare Outcomes and Policy, University of Michigan, Ann Arbor.

Abstract

This cohort study uses the National Cancer Database to examine changes in rates of diagnosis of thyroid cancer among Medicaid beneficiaries after Medicaid expansion in 2014.

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Adult
Aged
Female
Humans
Incidence
Male
Medicaid*
Middle Aged
Patient Protection and Affordable Care Act*
Thyroid Neoplasms / diagnosis*
Thyroid Neoplasms / epidemiology*
United States / epidemiology